Nov 14 (Reuters) - Theratechnologies Inc TH.TO :
* Theratechnologies Inc says announces decision by FDA to extend ibalizumab review period to April 3, 2018
Nov 14 (Reuters) - Theratechnologies Inc TH.TO :
* Theratechnologies Inc says announces decision by FDA to extend ibalizumab review period to April 3, 2018